propranolol has been researched along with Parkinson Disease, Secondary in 12 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of arotinolol, a peripherally acting beta-adrenergic-blocking agent, on postural or kinetic tremor was studied in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism." | 7.68 | Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys. ( Kuno, S; Mizuta, E; Nishida, J; Takechi, M, 1992) |
| "We present two cases of acute nocturnal bruxism occurring as an early side effect of antipsychotic drug treatment." | 5.30 | Bruxism secondary to antipsychotic drug exposure: a positive response to propranolol. ( Amir, I; Gavish, A; Hermesh, H, 1997) |
| "The effect of arotinolol, a peripherally acting beta-adrenergic-blocking agent, on postural or kinetic tremor was studied in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism." | 3.68 | Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys. ( Kuno, S; Mizuta, E; Nishida, J; Takechi, M, 1992) |
| "We present two cases of acute nocturnal bruxism occurring as an early side effect of antipsychotic drug treatment." | 1.30 | Bruxism secondary to antipsychotic drug exposure: a positive response to propranolol. ( Amir, I; Gavish, A; Hermesh, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulik, FA | 1 |
| Wilbur, R | 1 |
| Lipinski, JF | 1 |
| Zubenko, GS | 1 |
| Cohen, BM | 1 |
| Barreira, PJ | 1 |
| Metzer, WS | 1 |
| Paige, SR | 1 |
| Newton, JE | 1 |
| Amir, I | 1 |
| Hermesh, H | 1 |
| Gavish, A | 1 |
| Ahlskog, JE | 1 |
| Gabriel, E | 1 |
| Karobath, M | 1 |
| Lenz, G | 1 |
| Rivera, VM | 1 |
| Keichian, AH | 1 |
| Oliver, RE | 1 |
| Kuno, S | 1 |
| Mizuta, E | 1 |
| Nishida, J | 1 |
| Takechi, M | 1 |
| Keepers, GA | 1 |
| Casey, DE | 1 |
| Gelenberg, AJ | 1 |
| Sandyk, R | 1 |
| Fang, P | 1 |
| MacDonald, I | 1 |
| Laver, M | 1 |
| Hua, A | 1 |
| Kincaid-Smith, P | 1 |
3 reviews available for propranolol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Medical treatment of later-stage motor problems of Parkinson disease.
Topics: Amantadine; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; | 1999 |
Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Akathisia, Drug-Induced; Amantadine; Antipsychotic Ag | 1986 |
Treating extrapyramidal reactions: some current issues.
Topics: Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Humans | 1987 |
1 trial available for propranolol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
Topics: Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Dyskine | 1993 |
8 other studies available for propranolol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Parkinson Disease, Second | 1980 |
Propranolol in the treatment of neuroleptic-induced akathisia.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Bipolar Disorder; Female; Humans; | 1984 |
Bruxism secondary to antipsychotic drug exposure: a positive response to propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Bruxism; Female; | 1997 |
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug | 1976 |
Persistent parkinsonism following neuroleptanalgesia.
Topics: Adolescent; Anesthesia, Inhalation; Anesthesia, Intravenous; Droperidol; Female; Fentanyl; Humans; L | 1975 |
Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic beta-Antagonists; Animals; Macaca fascicula | 1992 |
Propranolol-induced tardive dyskinesia in a patient with akathisia.
Topics: Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Middle Aged; Parkinson Disease, Secondary; Pr | 1985 |
Oral diazoxide in uncontrolled malignant hypertension.
Topics: Administration, Oral; Creatinine; Diazoxide; Edema; Furosemide; Humans; Hypertension, Malignant; Hyp | 1974 |